Plumbline Life Sciences, Inc. concluded an agreement to acquire animal health assets of VGX Animal Health, Inc. on May 27, 2014. Under the terms of agreement, consideration includes $2 million in cash in multiple payments, 20% of the outstanding shares of Plumbline Life Sciences. The animal health assets being transferred includes exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license to Inovio electroporation delivery systems.

Plumbline Life Sciences, Inc. cancelled the acquisition of animal health assets of VGX Animal Health, Inc. on May 27, 2015.